MENTICE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.6 SEK | -0.94% |
|
+8.59% | -33.75% |
| May. 16 | Mentice Receives USD 2.26 Million Order for Simulation Solutions from a Top 20 Global MedTech Company | CI |
| May. 03 | Mentice AB to Seeks Acquisitions | CI |
Presenter SpeechDominic Steffel (Executives)Hello, and welcome to this presentation of the sec...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Mentice AB is a Sweden-based medical technology company. It provides software and hardware simulation solutions and related services for endovascular therapies. The Companyâs solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Companyâs solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The Company also covers neurovascular, cardiovascular and peripheral interventions, among others. It is active globally.
Calendar
2024-05-22
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
31.9
SEK
Average target price
45
SEK
Spread / Average Target
+41.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -33.75% | 76.22M | |
| +72.98% | 12.38B | |
| -20.40% | 7.76B | |
| +6.24% | 6.61B | |
| +12.78% | 5.4B | |
| +38.73% | 4.96B | |
| -17.50% | 4.75B | |
| -24.72% | 3.89B | |
| -29.57% | 2.66B | |
| +52.38% | 2.45B |
- Stock Market
- Equities
- MNTC Stock
- News Mentice AB
- Transcript : Mentice AB, Q2 2020 Earnings Call, Aug 13, 2020